Related Experiment Video
Updated: Jul 20, 2026
06:25
Evaluating Toxicity of Chemicals using a Zebrafish Vibration Startle Response Screening System
Published on: January 12, 2024
TCDD exposure-response analysis and risk assessment
Hong Cheng1, Lesa Aylward, Colleen Beall
1Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, USA. hcheng@ms.soph.uab.edu
Risk Analysis : an Official Publication of the Society for Risk Analysis
|September 5, 2006
Summary
This study found no significant link between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure and cancer mortality in workers. However, a positive association emerged when extreme exposure values were excluded, suggesting TCDD may increase cancer risk.
Area of Science:
- Environmental Health
- Toxicology
- Occupational Medicine
Background:
- Occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a concern for worker health.
- Accurate estimation of TCDD exposure and its long-term health effects, including cancer mortality, is crucial.
Purpose of the Study:
- To investigate the relationship between cumulative TCDD exposure and cancer mortality in occupationally exposed workers.
- To estimate incremental cancer risks at age 75 using a refined kinetic model for TCDD elimination.
Main Methods:
- Analysis of data from 3,538 workers from the National Institute for Occupational Safety and Health study.
- Utilized standardized mortality ratios and Cox regression, adjusting for confounders like age, birth year, and race.
- Employed a time-dependent kinetic model for TCDD elimination, considering concentration and age, and analyzed exposure lag periods.
Main Results:
- No statistically significant association between TCDD exposure and cancer mortality was found using the full dataset.
- A positive association between TCDD and cancer mortality was observed when restricting analysis to exposures below the 95th percentile, especially with a 15-year lag.
- Estimated incremental lifetime cancer mortality risks were substantially lower (6-10 times) than previous estimates.
Conclusions:
- The study suggests that TCDD exposure may be associated with increased cancer mortality, particularly at lower exposure levels or with longer lag times.
- Refined exposure modeling, accounting for TCDD elimination kinetics, leads to revised and lower risk estimates compared to earlier models.
Related Concept Videos
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
01:26Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...